Navigation Links
Chronic Metamphetamine Abuse is Related to Cardiovascular Disease

Until about six years ago, methamphetamine use was seen mostly in the western and rural United States. Today, methamphetamine abuse has expanded rapidly throughout the rest of the country and across different ethnic groups. In recent years, the spread of methamphetamine abuse across the United States has been as rapid as it has been alarming.

According to the 2005 National Survey on Drug Use and Health (NSDUH), an estimated 10.4 million Americans ages 12 or older have used methamphetamine at least once in their lifetimes for non-medical reasons.

The study showed that long-term methamphetamine use changes endogenous proteins in drug users, causing aberrant immune responses. As a result, increased levels of proinflammatory cytokines-proteins involved in immune response-may be a previously unrecognized molecular mechanism for the development of cardiovascular disorders such as vasculitus, an inflammation of the blood vessels.

Our previous studies showed that methamphetamine can glycate or add sugars to proteins, said Scripps Research Professor Kim Janda, who conducted this study in collaboration with Scripps Research Assistant Professor Tobin Dickerson and other colleagues. In this study, we found that the immune system responds dramatically to this methamphetamine-induced glycation, which may lead to vascular inflammation and deterioration if left untreated. These problems are the direct result of long-term methamphetamine abuse.

Previous studies may have missed the impact of chronic methamphetamine use on the vascular periphery, Janda said, because they focused on the response of the microglia-the immune cells of the central nervous system-and the appearance of methamphetamine-related neurotoxicity in the central nervous system.

The study found that there was a direct relationship between methamphetamine intake and the level of circulating antibodies in animal models. This immune response, cou pled with antibodies binding to methamphetamine, might make the drug less biologically available leading to an increased need for higher and higher doses, a problem found among chronic methamphetamine users.

The resulting glycated proteins-called advanced glycation endproducts (AGEs)-are associated with a number of diseases including diabetes and Alzheimers disease. Long-lived AGEs can easily modify protein function, initiate adverse cellular reactions, and form damaging deposits on arterial walls.

Methamphetamine-AGE proteins not only increased antibody production, the study said, but were strong enough to overcome the drugs natural immunosuppressive qualities. In addition, a wide range of cytokines directly linked to AGE exposure were increased in rats that self-administered methamphetamine.

The study also showed that even limited daily access to the drug was enough to produce an over-expression of vascular endothelial growth factor (VEGF), a potent signaling cytokine involved in angiogenesis and vasodilation. Our data suggest that even methamphetamine use at lower doses may be enough to increase VEGF to potentially detrimental levels, Janda said.

In addition to Janda and Dickerson, both of Scripps Researchs Skaggs Institute for Chemical Biology and Worm Institute for Research and Medicine, authors of the study, Self-Vaccination by Methamphetamine Glycation Products Chemically Links Chronic Drug Abuse and Cardiovascular Disease, include Scripps Research investigators Jennifer Treweek, George F. Koob, and Sunmee Wee.


'"/>




Related medicine news :

1. Roller coasters – cause “Chronic Headache?
2. In Chronic Diseases - Poor compliance of Patients with drug treatment
3. New Treatment for Chronic Eczema
4. Novel Therapy for Chronic Problem
5. Overcoming Chronic Fatigue
6. Chronic Fatigue, Pain Linked to Sinusitis
7. Chronic Diseases said to Cause Falls in the Elderly
8. Epilepsy Drug May Relieve Chronic Headaches
9. Women Worse Affected By Chronic Cough
10. A Drug That Might Relieve Chronic Cough
11. A Sedentary Childhood Could Lead To Chronic Fatigue Latter In Life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... 2017 , ... Cheerag D. Upadhyaya , M.D., M.Sc., FAANS has been ... (SLMBNI), part of Saint Luke’s Health System . Dr. Upadhyaya has served in ... M.Sc., FAANS joins Stanley P. Fisher, M.D., who has served as medical ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... Cosmetic Town, ... doctors and the cosmetic surgeries they perform on a daily basis. , The ... cosmetic surgery procedures they specialize in at their practices. , When asked about ...
(Date:7/24/2017)... Hagerstown, MD (PRWEB) , ... July 24, 2017 ... ... County Public Schools (MCPS) have partnered together for a unique opportunity that helps high ... their mission of “Removing Barriers, Creating Opportunities.” Horizon Goodwill will host over ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... $1,000 total in scholarship awards to be awarded annually to and divided between ... an interest in bringing awareness to Amazonian plant medicine. To apply for the ...
(Date:7/24/2017)... ... 2017 , ... Every year, thousands of dedicated Higher Education and K12 professionals ... is coupled with a dynamic theme like Camp Canvas; this year, they’ve managed to ... , To extend their partnership with Canvas beyond the LMS integration, Modo Labs ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... GAITHERSBURG, Md. , July 10, 2017 ... in non-animal test methods, is the recipient of a ... by the PETA International Science Consortium. The device, which ... be used to expose human lung cells to airborne ... lung. IIVS will use the VITROCELL® system for testing ...
(Date:7/10/2017)... July 10, 2017 Locus Biosciences Inc. today ... support the development of CRISPR-Cas3 antimicrobial therapeutics. Financing for ... leading Chinese Internet services provider, and joined by the ... infectious disease product programs targeting antibiotic resistant infections and ... Founded by Dr. Rodolphe Barrangou and Dr. ...
(Date:7/5/2017)... , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company focused ... that it has received approval from the Israel Securities Authority ... Exchange (TASE). Oramed common stock will commence trading on the ... on the current market capitalization of the Company, it is ...
Breaking Medicine Technology: